NRPH Insider Trading Activity and SEC Form 4 Filings
NRPH insider trading summary
No open-market insider purchases or sales of New River Pharmaceuticals Inc (NRPH) have been reported on SEC Form 4 in the past 12 months.
Latest NRPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 19, 2007 | Burton E Sobel | Director | Sell | $281K (5,000 @ $56.10) |
| Jan 3, 2007 | Larry D Horner | Director | Sell | $822K (15,000 @ $54.83) |
| Jan 3, 2007 | Burton E Sobel | Director | Sell | $137K (2,500 @ $54.83) |
| Jan 3, 2007 | David S Barlow | Director | Sell | $548K (10,000 @ $54.83) |
| Dec 4, 2006 | Larry D Horner | Director | Sell | $493K (10,000 @ $49.25) |
| Dec 4, 2006 | Larry D Horner | Director | Sell | $739K (15,000 @ $49.25) |
| Dec 1, 2006 | David S Barlow | Director | Sell | $490K (10,000 @ $49.01) |
| Dec 1, 2006 | Burton E Sobel | Director | Sell | $368K (7,500 @ $49.01) |
| Nov 10, 2006 | New River Management II, LP | 10% Owner | Sell | $1.4M (28,353 @ $48.23) |
| Nov 10, 2006 | Randal J Kirk | Chairman, President and CEO | Sell | $605K (12,554 @ $48.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.